Differential occurrence of protein intrinsic disorder in the cytoplasmic signaling domains of cell receptors

Self/Nonself - Immune Recognition and Signaling

Volumn 2, Issue 1, 2011, Pages 55-72

  Sigalov, Alexander B ^a   Uversky, Vladimir N ^b,c,d  

^a SignaBlok Inc   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

Author keywords

B cell receptor; Immune signaling; Intrinsically disordered proteins; Mirr; Multichain immune recognition receptors; Protein disorder; Receptor tyrosine kinases; Rtk; Single chain receptors; T cell receptor

Indexed keywords

B LYMPHOCYTE RECEPTOR; CYTOKINE RECEPTOR; CYTOPLASMIC RECEPTOR; FC RECEPTOR; INTRINSICALLY DISORDERED PROTEIN; MULTICHAIN RECEPTOR; PROTEIN; PROTEIN TYROSINE KINASE; SINGLE CHAIN RECEPTOR; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CYTOPLASMIC SIGNALING; INTRACELLULAR SIGNALING; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN STRUCTURE;

EID: 79960371484     PISSN: 19382030     EISSN: 19382049     Source Type: Journal    
DOI: 10.4161/self.2.1.14790     Document Type: Article

References (60)

1. Rudd CE. Disabled receptor signaling and new primary immunodeficiency disorders. N Engl J Med 2006; 354:1874-1877.
2. Sigalov AB, Ed. Multichain immune recognition receptor signaling: From spatiotemporal organization to human disease. New York: Springer-Verlag 2008; 357.
3. Uversky VN, Gillespie JR, Fink AL. Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins 2000; 41:415-427.
4. Iakoucheva LM, Brown CJ, Lawson JD, Obradovic Z, Dunker AK. Intrinsic disorder in cell-signaling and cancer-associated proteins. J Mol Biol 2002; 323:573-584.
5. Iakoucheva LM, Radivojac P, Brown CJ, O'Connor TR, Sikes JG, Obradovic Z, et al. The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res 2004; 32:1037-1049.
6. Minezaki Y, Homma K, Nishikawa K. Intrinsically disordered regions of human plasma membrane proteins preferentially occur in the cytoplasmic segment. J Mol Biol 2007; 368:902-913.
7. De Biasio A, Guarnaccia C, Popovic M, Uversky VN, Pintar A, Pongor S. Prevalence of intrinsic disorder in the intracellular region of human single-pass type I proteins: The case of the notch ligand Delta-4. J Proteome Res 2008; 7:2496-2506.
8. Kukhtina NB, Arefieva TI, Krasnikova TL. Intracellular signal cascade in CD4+ T-lymphocyte migration stimulated by interferon-gamma-inducible protein-10. Biochemistry (Mosc) 2005; 70:652-656.
9. Sigalov AB. The SCHOOL of nature. I. Transmembrane signaling. Self/Nonself-Immune Recognition and Signaling 2010; 1:4-39.
10. Keegan AD, Paul WE. Multichain immune recognition receptors: Similarities in structure and signaling pathways. Immunol Today 1992; 13:63-68.
11. Sigalov A. Multi-chain immune recognition receptors: Spatial organization and signal transduction. Semin Immunol 2005; 17:51-64.
12. Sigalov AB. Multichain immune recognition receptor signaling: different players, same game? Trends Immunol 2004; 25:583-589.
13. Sigalov AB. Protein intrinsic disorder and oligomericity in cell signaling. Mol Biosyst 2010; 6:451-461.
14. Sigalov A, Aivazian D, Stern L. Homooligomerization of the cytoplasmic domain of the T cell receptor zeta chain and of other proteins containing the immunoreceptor tyrosine-based activation motif. Biochemistry 2004; 43:2049-2061.
15. Sigalov AB, Aivazian DA, Uversky VN, Stern LJ. Lipid-binding activity of intrinsically unstructured cytoplasmic domains of multichain immune recognition receptor signaling subunits. Biochemistry 2006; 45:15731-15739.
16. Sigalov AB, Zhuravleva AV, Orekhov VY. Binding of intrinsically disordered proteins is not necessarily accompanied by a structural transition to a folded form. Biochimie 2007; 89:419-421.
17. Sigalov AB. The SCHOOL of nature. II. Protein order, disorder and oligomericity in transmembrane signaling. Self/Nonself-Immune Recognition and Signaling 2010; 1:89-102.
18. Sigalov AB. Unusual biophysics of immune signalingrelated intrinsically disordered proteins. Self/Nonself-Immune Recognition and Signaling 2010; 1:271-281.
19. Ortega E. How do multichain immune recognition receptors signal? A structural hypothesis. Mol Immunol 1995; 32:941-5.
20. Berko D, Carmi Y, Cafri G, Ben-Zaken S, Sheikhet HM, Tzehoval E, et al. Membrane-anchored beta 2-microglobulin stabilizes a highly receptive state of MHC class I molecules. J Immunol 2005; 174:2116-2123.
21. Sigalov AB. Protein intrinsic disorder and oligomericity in cell signaling. Mol Biosyst 2010; 6:451-461.
22. Dunker AK, Lawson JD, Brown CJ, Williams RM, Romero P, Oh JS, et al. Intrinsically disordered protein. J Mol Graph Model 2001; 19:26-59.
23. Vacic V, Uversky VN, Dunker AK, Lonardi S. Composition Profiler: A tool for discovery and visualization of amino acid composition differences. BMC Bioinformatics 2007; 8:211.
24. Radivojac P, Iakoucheva LM, Oldfield CJ, Obradovic Z, Uversky VN, Dunker AK. Intrinsic disorder and functional proteomics. Biophys J 2007; 92:1439-1456.
25. Campen A, Williams RM, Brown CJ, Meng J, Uversky VN, Dunker AK. TOP-IDP-scale: a new amino acid scale measuring propensity for intrinsic disorder. Protein Pept Lett 2008; 15:956-963.
26. Sickmeier M, Hamilton JA, LeGall T, Vacic V, Cortese MS, Tantos A, et al. DisProt: The database of disordered roteins. Nucleic Acids Res 2007; 35:786-793.
27. Romero P, Obradovic Z, Li X, Garner EC, Brown CJ, Dunker AK. Sequence complexity of disordered protein. Proteins 2001; 42:38-48.
28. Oldfield CJ, Cheng Y, Cortese MS, Brown CJ, Uversky N, Dunker AK. Comparing and combining predictors f mostly disordered proteins. Biochemistry 2005; 44:1989-2000.
29. Dunker AK, Obradovic Z, Romero P, Garner EC, Brown CJ. Intrinsic protein disorder in complete genomes. Genome Inform Ser Workshop Genome Inform 2000; 11:161-171.
30. Mohan A, Sullivan WJ Jr, Radivojac P, Dunker AK, Uversky VN. Intrinsic disorder in pathogenic and nonpathogenic microbes: discovering and analyzing the unfoldomes of early-branching eukaryotes. Mol Biosyst 2008; 4:328-30.
31. Kim PM, Sboner A, Xia Y, Gerstein M. The role of disorder in interaction networks: A structural analysis. Mol Syst Biol 2008; 4:179.
32. Fong JH, Panchenko AR. Intrinsic disorder and protein multibinding in domain, terminal and linker regions. Mol Biosyst 2010; 6:1821-8.
33. Fong JH, Shoemaker BA, Garbuzynskiy SO, Lobanov MY, Galzitskaya OV, Panchenko AR. Intrinsic disorder in protein interactions: insights from a comprehensive structural analysis. PLoS Comput Biol 2009; 5:1000316.
34. Oldfield CJ, Cheng Y, Cortese MS, Romero P, Uversky VN, Dunker AK. Coupled folding and binding with alpha-helix-forming molecular recognition elements. Biochemistry 2005; 44:12454-12470.
35. Cheng Y, Oldfield CJ, Meng J, Romero P, Uversky VN, Dunker AK. Mining alpha-helix-forming molecular recognition features with cross species sequence alignments. Biochemistry 2007; 46:13468-13477.
36. Mohan A, Oldfield CJ, Radivojac P, Vacic V, Cortese MS, Dunker AK, et al. Analysis of molecular recognition features (MoRFs). J Mol Biol 2006; 362:1043-1059.
37. Vacic V, Oldfield CJ, Mohan A, Radivojac P, Cortese MS, Uversky VN, et al. Characterization of molecular recognition features, MoRFs and their binding partners. J Proteome Res 2007; 6:2351-2366.
38. Sigalov AB, Kim WM, Saline M, Stern LJ. The intrinsically disordered cytoplasmic domain of the T Cell receptor zeta chain binds to the Nef protein of Simian immunodeficiency virus without a disorder-to-order transition. Biochemistry 2008; 47:12942-4.
39. Williams RJ. Signalling: Basics and evolution. Acta Biochim Pol 2004; 51:281-298.
40. Hashimoto K, Madej T, Bryant SH, Panchenko AR. Functional states of homooligomers: Insights from the evolution of glycosyltransferases. J Mol Biol 2010; 399:196-206.
41. Sigalov AB. Signaling chain homooligomerization (SCHOOL) model. Adv Exp Med Biol 2008; 640:121-163.
42. Hegyi H, Schad E, Tompa P. Structural disorder promotes assembly of protein complexes. BMC Struct Biol 2007; 7:65.
43. Reth M. Antigen receptor tail clue. Nature 1989; 338:383-384.
44. Wu J, Cherwinski H, Spies T, Phillips JH, Lanier LL. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J Exp Med 2000; 192:1059-1068.
45. Pitcher LA, van Oers NS. T-cell receptor signal transmission: Who gives an ITAM? Trends Immunol 2003; 24:554-650
46. Pike KA, Baig E, Ratcliffe MJ. The avian B-cell receptor complex: Distinct roles of Igalpha and Igbeta in B-cell development. Immunol Rev 2004; 197:10-25.
47. Storch B, Meixlsperger S, Jumaa H. The Igalpha ITAM is required for efficient differentiation but not proliferation of pre-B cells. Eur J Immunol 2007; 37:252-260.
48. Gazumyan A, Reichlin A, Nussenzweig MC. Igbeta tyrosine residues contribute to the control of B cell receptor signaling by regulating receptor internalization. J Exp Med 2006; 203:1785-1794.
49. Lin S, Cicala C, Scharenberg AM, Kinet JP. The Fc(epsilon)RIbeta subunit functions as an amplifier of Fc(epsilon)RIgamma-mediated cell activation signals. Cell 1996; 85:985-995.
50. Sanchez-Mejorada G, Rosales C. Signal transduction by immunoglobulin Fc receptors. J Leukoc Biol 1998; 63:521-533.
51. Lysechko TL, Ostergaard HL. Differential Src family kinase activity requirements for CD3zeta phosphorylation/ZAP70 recruitment and CD3epsilon phosphorylation. J Immunol 2005; 174:7807-7814.
52. Kuhns MS, Davis MM. Disruption of extracellular interactions impairs T cell receptor-CD3 complex stability and signaling. Immunity 2007; 26:357-369.
53. Chau LA, Bluestone JA, Madrenas J. Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptor. J Exp Med 1998; 187:1699-1709.
54. Jensen WA, Pleiman CM, Beaufils P, Wegener AM, Malissen B, Cambier JC. Qualitatively distinct signaling through T cell antigen receptor subunits. Eur J Immunol 1997; 27:707-716.
55. Pitcher LA, Mathis MA, Young JA, Deford LM, Purtic B, Wulfing C, et al. The CD3gammaepsilon/deltaepsilon signaling module provides normal T cell functions in the absence of the TCRzeta immunoreceptor tyrosine-based activation motifs. Eur J Immunol 2005; 35:3643-5364.
56. Kesti T, Ruppelt A, Wang JH, Liss M, Wagner R, Tasken K, et al. Reciprocal regulation of SH3 and SH2 domain binding via tyrosine phosphorylation of a common site in CD3{epsilon}. J Immunol 2007; 179:878-885.
57. Chae WJ, Lee HK, Han JH, Kim SW, Bothwell AL, Morio T, et al. Qualitatively differential regulation of T cell activation and apoptosis by T cell receptor zeta chain ITAMs and their tyrosine residues. Int Immunol 2004; 16:1225-1236.
58. Cheng Y, LeGall T, Oldfield CJ, Dunker AK, Uversky VN. Abundance of intrinsic disorder in protein associated with cardiovascular disease. Biochemistry 2006; 45:10448-10460.
59. Garner E, Romero P, Dunker AK, Brown C, Obradovic Z. Predicting binding regions within disordered proteins. Genome Inform Ser Workshop Genome Inform 1999; 10:41-50.
60. Callaghan AJ, Aurikko JP, Ilag LL, Gunter Grossmann J, Chandran V, Kuhnel K, et al. Studies of the RNA degradosome-organizing domain of the Escherichia coli ribonuclease RNase E. J Mol Biol 2004; 340:965-979.